All News

Five ways to truly stand out, and make a great impression on IPPE and APPE rotations.

Marketing tactics for this drug have been cited as one cause of the national crisis.

Combination of Lenvima and Keytruda awarded second Breakthrough Therapy designation for the treatment of endometrial carcinoma.

Survey authors identified an unmet need for clinician engagement regarding financial concerns after breast cancer diagnosis.

HIV-associated cardiovascular disease is on the rise among individuals living with the virus, particularly in regions with limited resources.

Advancements in breast cancer treatment have improved survival rates, but financial hardships related to the cost of these lifesaving therapies can weigh heavily on patients.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The FDA has granted approval to a pair of assays designated for the use with an immunodiagnostic system that detects hepatitis B (HBV) in individuals.

Which LVAD type is better?

The FDA has approved the longest-lasting self-applied continuous glucose monitor (CGM) in the United States market.

Fenfluramine, a drug that was previously sold as an appetite suppressant before it was withdrawn from the market in 1997 over concerns about its link to heart valve problems, may have a new application.

The CDC is currently investigating an outbreak of Salmonella infections linked to raw turkey products.

Survey findings indicate that patients with breast cancer worry about financial hardships related to their treatment, yet many do not feel providers adequately address these concerns.

The Archives of Disease in Childhood, Education and Practice Edition has published a manuscript that describes a structured approach to chronic cough in children.

The FDA has approved lusutrombopag (Mulpleta) for the treatment of thrombocytopenia in particular adults with chronic liver disease.

Interferon regulatory factor 2 binding protein-like gene is essential for neurological development and maintenance.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Although it can lead to death, PCP is preventable with appropriate prophylaxis therapy given to patients at high risk of infection.

Each group reported a thrombosis-related adverse event rate of 1.9%.

The FDA is warning consumers against serious risks of some ‘vaginal rejuvenation’ devices, and a lack of evidence to support their uses for this purpose.

Hepatitis B virus core inhibitor under evaluation in a pair of global phase 2a proof of concept studies.

In a groundbreaking new study, researchers have identified a molecular pathway for stimulating the regeneration of new myelinating cells, and repairing the damage of debilitating neurological diseases.

Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders.

The FDA has approved iobenguane I-131 (Azedra) for adult and pediatric patients aged ≥12 years with iobenguane scan–positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Study finds that several multiple sclerosis drug candidates inhibit the same enzyme to stimulate myelin regeneration.

Earlier in the month, FDA officials announced that several, but not all, drug products containing the active ingredient valsartan, were recalled due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products.